These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3926200)

  • 21. Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes.
    Chacra AR; Kipnes M; Ilag LL; Sarwat S; Giaconia J; Chan J;
    Diabet Med; 2010 May; 27(5):563-9. PubMed ID: 20536953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.
    Wilson DM; Calhoun PM; Maahs DM; Chase HP; Messer L; Buckingham BA; Aye T; Clinton PK; Hramiak I; Kollman C; Beck RW;
    Diabetes Technol Ther; 2015 Jun; 17(6):385-91. PubMed ID: 25761202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin.
    Dailey GE; Gao L; Aurand L; Garg SK
    Diabetes Obes Metab; 2013 Dec; 15(12):1085-92. PubMed ID: 23683002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients.
    Pramming S; Thorsteinsson B; Bendtson I; Binder C
    J Intern Med; 1990 Dec; 228(6):641-6. PubMed ID: 2280242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus.
    Porter PA; Byrne G; Stick S; Jones TW
    Arch Dis Child; 1996 Aug; 75(2):120-3. PubMed ID: 8869191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocturnal Hypoglycaemia in Patients with Diabetes Mellitus: Database Analysis of a Cohort Using Telemedicine Support for Self-Monitoring of Blood Glucose over a 10-Year-Long Period.
    Jermendy G; Kecskes A; Nagy A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33672913
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials.
    Rosenstock J; Marre M; Qu Y; Zhang S; Bastyr EJ; Prince MJ; Chang AM
    Diabetes Obes Metab; 2016 Nov; 18(11):1093-1097. PubMed ID: 27484021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
    Ratner RE; Hirsch IB; Neifing JL; Garg SK; Mecca TE; Wilson CA
    Diabetes Care; 2000 May; 23(5):639-43. PubMed ID: 10834423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.
    Home PD; Rosskamp R; Forjanic-Klapproth J; Dressler A;
    Diabetes Metab Res Rev; 2005; 21(6):545-53. PubMed ID: 16021649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin.
    Pieber TR; Draeger E; Kristensen A; Grill V
    Diabet Med; 2005 Jul; 22(7):850-7. PubMed ID: 15975098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.
    Malone JK; Bai S; Campaigne BN; Reviriego J; Augendre-Ferrante B
    Diabet Med; 2005 Apr; 22(4):374-81. PubMed ID: 15787659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes.
    Christiansen JS; Vaz JA; Metelko Z; Bogoev M; Dedov I
    Diabetes Obes Metab; 2003 Nov; 5(6):446-54. PubMed ID: 14617231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction.
    Lind M; Jendle J; Torffvit O; Lager I
    Prim Care Diabetes; 2012 Apr; 6(1):41-6. PubMed ID: 22015237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocturnal electroencephalogram registrations in type 1 (insulin-dependent) diabetic patients with hypoglycaemia.
    Bendtson I; Gade J; Rosenfalck AM; Thomsen CE; Wildschiødtz G; Binder C
    Diabetologia; 1991 Oct; 34(10):750-6. PubMed ID: 1959707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
    Hemmingsen B; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive function in type 1 (insulin-dependent) diabetic patients after nocturnal hypoglycaemia.
    Bendtson I; Gade J; Theilgaard A; Binder C
    Diabetologia; 1992 Sep; 35(9):898-903. PubMed ID: 1397787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
    Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
    N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5).
    Ólafsdóttir AF; Bolinder J; Heise T; Polonsky W; Ekelund M; Wijkman M; Pivodic A; Ahlén E; Schwarcz E; Nyström T; Hellman J; Hirsch IB; Lind M
    Diabetes Obes Metab; 2021 Feb; 23(2):619-630. PubMed ID: 33200487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.